세계 백혈병 스크리닝 시장 : 검사 유형별, 질환 유형별, 연령층별, 최종 사용자별, 지역별
Leukemia Screening Market, By Test Type, By Disease Type, By Age Group, By End User, By Geography
상품코드
:
1391906
리서치사
:
Coherent Market Insights
발행일
:
2023년 11월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계 백혈병 스크리닝 시장은 2023년에 72억 8,000만 달러로 추정되었고, 2030년에는 116억 6,000만 달러에 이를 것으로 예측되며, 예측 기간 동안 7%의 복합 연간 성장률(CAGR) 를 나타낼 것으로 보입니다.
| 보고 범위 |
보고서 세부정보 |
| 기준년 |
2022년 |
2023년 시장 규모 |
72억 8,000만 달러 |
| 과거 데이터 |
2018-2021년 |
예측 기간 |
2023-2030년 |
| 예측 기간의 CAGR |
7.00% |
2030년 시장 규모 예측 |
116억 6,000만 달러 |
그림 1. 백혈병 스크리닝 세계 시장 점유율(%), 지역별, 2023년
백혈병은 혈액세포를 침범하는 암의 일종입니다. 백혈병은 많은 사망자를 낳는 심각한 질병이며, 가족과 건강 관리 시스템에 큰 부담을주고 있습니다. 백혈병의 주요 진단 수단은 임상 및 신체 검사입니다. 전혈구 산정(CBC)은 신체의 적혈구, 백혈구 및 혈소판 수준을 조사했습니다. 비정상적인 백혈구가 많으면 백혈병의 가능성이 있습니다. 백혈병 세포의 유형에 따라서는 혈액중을 순환하는 것도 있고, 골수에 머물러 루틴의 혈액 검사에서는 나타나지 않는 것도 있습니다. 세계 백혈병 스크리닝 시장은 세계에서 다양한 유형의 백혈병 발생률이 증가하고 있기 때문에 지난 몇 년간 현저한 성장을 이루고 있습니다. 백혈병은 골수로 시작하여 비정상적인 백혈구가 다발하는 혈액암의 일종입니다. 환경 오염 확대, 생활 습관 변화, 세계 인구 고령화로 백혈병 환자는 꾸준히 증가하고 있습니다. 그 결과, 백혈병을 조기에 발견하기 위한 고도의 스크리닝 검사에 대한 수요가 선진국에서도 개발도상국에서도 높아지고 있습니다. 백혈병 및 혁신적인 스크리닝 솔루션의 가용성에 대한 인식을 높이기 위한 다양한 공공 및 민간 이니셔티브는 세계 백혈병 스크리닝 산업을 더욱 추진하고 있습니다.
본 조사의 주요 특징
- 본 보고서는 세계 백혈병 스크리닝 시장을 상세하게 분석하여 2022년을 기준년으로 한 예측기간(2023-2030년) 시장 규모 및 복합 연간 성장률(CAGR%)을 제공합니다.
- 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장에 대한 매력적인 투자 제안의 행렬을 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개변수를 바탕으로 세계 백혈병 스크리닝 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진이 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 백혈병 스크리닝 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계 백혈병 스크리닝 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 백혈병 발생률 증가
- 고액의 스크리닝 비용
- 신흥국 시장에서의 확대
- 주요 하이라이트
- 규제 시나리오
- 최근 동향
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 합병, 인수 및 협업
제4장 세계 백혈병 스크리닝 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 신형 코로나 바이러스 감염증(COVID-19)의 역학
- 공급측과 수요측 분석
- 경제적 영향
제5장 세계 백혈병 스크리닝 시장 - 검사 유형별(2018-2030년)
- 전혈구 계산(CBC)
- 골수천자 및 생검
- 유세포 분석
- 세포유전학적 분석
- 중합효소 연쇄반응(PCR)
- 면역표현형 검사
- 기타
제6장 세계 백혈병 스크리닝 시장 - 질환 유형별(2018-2030년)
- 급성 림프성 백혈병(ALL)
- 급성 골수성 백혈병(AML)
- 만성 림프성 백혈병(CLL)
- 만성 골수성 백혈병(CML)
- 기타
제7장 세계 백혈병 스크리닝 시장 - 연령층별(2018-2030년)
제8장 세계 백혈병 스크리닝 시장 - 최종 사용자별(2018-2030년)
제9장 세계 백혈병 스크리닝 시장 - 지역별(2018-2030년)
- 북미
- 미국
- 캐나다
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 중앙 아프리카
- 북아프리카
제10장 경쟁 구도
- 기업 프로파일
- F.Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- QIAGEN NV
- Beckman Coulter, Inc.
- Adaptive Biotechnologies Corporation
- Invivoscribe, Inc.
- ArcherDX, Inc.
제11장 섹션
JHS
영문 목차
Global leukemia screening market is estimated to be valued at US$ 7.28 Bn in 2023 and is expected to reach US$ 11.66 Bn by 2030, exhibiting a compound annual growth rate (CAGR) of 7% during the forecast period.
| Report Coverage |
Report Details |
| Base Year: |
2022 |
Market Size in 2023: |
US$ 7.28 Bn |
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: |
7.00% |
2030 Value Projection: |
US$ 11.66 Bn |
Figure 1. Global Leukemia Screening Market Share (%), By Region, 2023
Leukemia is a type of cancer that affects blood cells. It is a serious condition that causes a high number of deaths, thereby creating a huge burden on families and the healthcare system. The main diagnostic tools for leukemia are laboratory tests and a physical exam. A complete blood count (CBC) checks the levels of red and white blood cells and platelets in the body. A high level of abnormal white cells can indicate leukemia. Some types of leukemia cells circulate in the blood, while others stay in the bone marrow and do not show up in a routine blood test. The global leukemia screening market has been witnessing notable growth over the past few years due to the rising incidence of different types of leukemia across the world. Leukemia is a type of blood cancer that starts in the bone marrow and results in a high number of abnormal white blood cells. There has been steady rise in leukemia cases due to growing environmental pollution, changing lifestyle habits, and increasing age of the population globally. As a consequence, demand for advanced screening tests for early detection of leukemia has increased in both developed and developing nations. Various public and private initiatives aimed at enhancing awareness about leukemia and availability of innovative screening solutions has further propelled the global leukemia screening industry.
Market Dynamics:
The market is expanding significantly as a result of factors such the increased prevalence of illnesses linked to legionella and pneumonia, as well as the growing need for quick, sophisticated diagnostic methods and developments in bacterial testing technology. A comparatively rare cause of community-acquired pneumonia is legionella pneumonia. For instance, in November 2022, according to a study published titled "Community-Acquired Pneumonia", the expected global incidence of community-acquired pneumonia ranges from 1.5 to 14 cases per 1000 person each year, with region, season, and population characteristics all having a part. Incidence rates rise with age, with 24.8 instances per 10,000 adults in the U.S. each year.
Key features of the study:
- This report provides in-depth analysis of the global leukemia screening market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global leukemia screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., QIAGEN N.V., Beckman Coulter, Inc., Adaptive Biotechnologies Corporation, Invivoscribe, Inc., and ArcherDX, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global leukemia screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukemia screening market
Detailed Segmentation:
- Global Leukemia Screening Market, By Test Type
- Complete Blood Count (CBC)
- Bone Marrow Aspiration and Biopsy
- Flow Cytometry
- Cytogenetic Analysis
- Polymerase Chain Reaction (PCR)
- Immunophenotyping
- Others
- Global Leukemia Screening Market, By Disease Type
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Others
- By Age Group
- Pediatric
- Adult
- Geriatric
- By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Others
- By Region
- North America
- Europe
- Latin America
- Middle East
- Africa
- Top Companies in the Global Leukemia Screening Market:
- F.Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- QIAGEN N.V.
- Beckman Coulter, Inc.
- Adaptive Biotechnologies Corporation
- Invivoscribe, Inc.
- ArcherDX, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By Disease Type
- Market Snippet, By Age Group
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing incidence of leukemia
- High cost of screening procedures
- Expansion in emerging markets
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Leukemia Screening Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Leukemia Screening Market, By Test Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Complete Blood Count (CBC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Bone Marrow Aspiration and Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Cytogenetic Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Immunophenotyping
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
6. Global Leukemia Screening Market, By Disease Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Acute Lymphoblastic Leukemia (ALL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Acute Myeloid Leukemia (AML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Chronic Lymphocytic Leukemia (CLL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Chronic Myeloid Leukemia (CML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
7. Global Leukemia Screening Market, By Age Group, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
8. Global Leukemia Screening Market, By End User, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
9. Global Leukemia Screening Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
- South Africa
- Central Africa
- North Africa
10. Competitive Landscape
- Company Profile
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Adaptive Biotechnologies Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- References
- Research Methodology
- About us
관련자료
